Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer

被引：0
|
作者：
Sabnis, Ram W. [1 ]
机构：
[1] Gambrell & Russell LLP, Smith, Atlanta, GA 30309 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 06期
关键词：
D O I：
10.1021/acsmedchemlett.4c00177
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Provided herein are novel 2,7-naphthyridine compounds as MASTL inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.
引用
收藏
页码：748 / 749
页数：2
相关论文
共 50 条
  • [31] LIQUID-CRYSTAL NUCLEAR MAGNETIC-RESONANCE INVESTIGATION ON STRUCTURE OF A MOLECULE FORMED BY 2 FUSED 6-MEMBERED RINGS - 2,7-NAPHTHYRIDINE
    DANIELI, R
    LUNAZZI, L
    VERACINI, CA
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1976, (01): : 19 - 20
  • [32] STUDIES ON SYNTHESES OF HETEROCYCLIC COMPOUNDS .430. SYNTHESIS OF CAMPTOTHECIN AND RELATED COMPOUNDS .2. SYNTHESIS OF 4-ETHYL-4-HYDROXY-5-METHOXY-6-METHYL-3-OXO-1,2,3,4-TETRAHYDRO-2,7-NAPHTHYRIDINE
    KAMETANI, T
    TAKANO, S
    NEMOTO, H
    TAKEDA, H
    YAKUGAKU ZASSHI, 1971, 91 (09): : 966 - &
  • [33] 1,7-Naphthyridine 1-Oxides as Novel Potent and Selective Inhibitors of p38 Mitogen Activated Protein Kinase
    Lumeras, Wenceslao
    Vidal, Laura
    Vidal, Bernat
    Balague, Cristina
    Orellana, Adelina
    Maldonado, Monica
    Dominguez, Maria
    Segarra, Victor
    Caturla, Francisco
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) : 7899 - 7910
  • [34] CHEMISTRY OF HETEROCYCLIC-COMPOUNDS .143. FUNCTIONALIZATION OF 2-METHYL-1,8-NAPHTHYRIDINE AND 2,7-DIMETHYL-1,8-NAPHTHYRIDINE
    NEWKOME, GR
    THERIOT, KJ
    MAJESTIC, VK
    SPRUELL, PA
    BAKER, GR
    JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (09): : 2838 - 2842
  • [35] Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes
    Kang, Minsung
    Kim, Chijung
    Leem, Jiyeon
    Kim, Ye-hyun
    Kwon, Young-ju
    Yoon, Yi Na
    Chae, Chong Hak
    Ahn, Jiyeon
    Jung, Kwan-Young
    Oh, Jeong Su
    Kim, Jae-Sung
    PHARMACEUTICALS, 2021, 14 (07)
  • [36] Unexpected synthesis, delayed emission and solid-state acidochromism of novel 2,7-naphthyridine derivatives obtained from 2-(3,5-diaryl-4H-pyran-4-ylidene)malononitrile
    Jiang, Yitian
    Liu, Miaochang
    Wang, Mengzhu
    Lei, Yunxiang
    Ding, Qiuping
    Wu, Huayue
    Huang, Xiaobo
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2022, 20 (39) : 7770 - 7775
  • [37] Synthesis of pyrrolo[2,3-c]2,7-naphthyridine derivatives by cascade heterocyclization reaction of 2-amino-4-cyanomethyl-6-dialkylamino-3,5-pyridinedicarbonitriles
    Tverdokhlebov, AV
    Resnyanska, EV
    Zavada, AV
    Tolmachev, AA
    Kostyuk, AN
    Chernega, AN
    TETRAHEDRON, 2004, 60 (27) : 5777 - 5783
  • [38] Synthesis and In vitro Antitumor Screening of Novel 2,7-Naphthyridine-3-carboxylic Acid Derivatives
    Wojcicka, Anna
    Wagner, Edwin
    Drys, Andrzej
    Nawrocka, Wanda Paulina
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2013, 50 (04) : 746 - 753
  • [39] Pyrrolopyrazine Compounds as ERK5 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 16 (01): : 16 - 17
  • [40] Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 777 - 778
12345